| Literature DB >> 2413687 |
T Ruzicka, M Meurer, O Braun-Falco.
Abstract
Nineteen patients with different clinical subsets of cutaneous lupus erythematosus (LE) were treated with the aromatic retinoid etretinate. In 11 of them excellent or good treatment results were obtained within two to six weeks. Best response to etretinate therapy was seen in male patients with discoid lupus erythematosus. Etretinate should prove a valuable drug in LE therapy.Entities:
Mesh：
Substances：
Year: 1985 PMID： 2413687
Source DB: PubMed Journal: Acta Derm Venereol ISSN： 0001-5555 Impact factor: 4.437